[PHARMA] QoQ TTM Result on 31-Mar-2011 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- 20.33%
YoY- -33.5%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 1,520,981 1,529,311 1,492,216 1,446,116 1,378,348 1,326,138 1,321,763 9.78%
PBT 73,186 54,117 53,876 54,823 45,462 75,653 69,675 3.32%
Tax -20,401 -15,466 -17,749 -18,223 -15,152 -21,273 -17,335 11.43%
NP 52,785 38,651 36,127 36,600 30,310 54,380 52,340 0.56%
-
NP to SH 52,157 37,959 35,734 36,561 30,384 54,554 52,027 0.16%
-
Tax Rate 27.88% 28.58% 32.94% 33.24% 33.33% 28.12% 24.88% -
Total Cost 1,468,196 1,490,660 1,456,089 1,409,516 1,348,038 1,271,758 1,269,423 10.15%
-
Net Worth 514,153 464,092 451,517 437,661 421,262 424,488 417,065 14.92%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 35,296 - - 50,261 50,261 89,852 118,755 -55.36%
Div Payout % 67.67% - - 137.47% 165.42% 164.70% 228.26% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 514,153 464,092 451,517 437,661 421,262 424,488 417,065 14.92%
NOSH 117,655 106,933 106,994 107,007 106,919 106,924 106,939 6.55%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 3.47% 2.53% 2.42% 2.53% 2.20% 4.10% 3.96% -
ROE 10.14% 8.18% 7.91% 8.35% 7.21% 12.85% 12.47% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 1,292.74 1,430.15 1,394.66 1,351.41 1,289.15 1,240.26 1,235.99 3.02%
EPS 44.33 35.50 33.40 34.17 28.42 51.02 48.65 -5.99%
DPS 30.00 0.00 0.00 47.00 47.00 84.00 111.00 -58.09%
NAPS 4.37 4.34 4.22 4.09 3.94 3.97 3.90 7.85%
Adjusted Per Share Value based on latest NOSH - 107,007
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 105.53 106.11 103.54 100.34 95.64 92.01 91.71 9.78%
EPS 3.62 2.63 2.48 2.54 2.11 3.79 3.61 0.18%
DPS 2.45 0.00 0.00 3.49 3.49 6.23 8.24 -55.35%
NAPS 0.3567 0.322 0.3133 0.3037 0.2923 0.2945 0.2894 14.91%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 5.36 5.90 5.90 5.73 5.31 4.98 4.98 -
P/RPS 0.41 0.41 0.42 0.42 0.41 0.40 0.40 1.65%
P/EPS 12.09 16.62 17.67 16.77 18.69 9.76 10.24 11.67%
EY 8.27 6.02 5.66 5.96 5.35 10.25 9.77 -10.48%
DY 5.60 0.00 0.00 8.20 8.85 16.87 22.29 -60.08%
P/NAPS 1.23 1.36 1.40 1.40 1.35 1.25 1.28 -2.61%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 -
Price 5.90 5.90 5.90 5.05 5.35 4.92 4.95 -
P/RPS 0.46 0.41 0.42 0.37 0.42 0.40 0.40 9.73%
P/EPS 13.31 16.62 17.67 14.78 18.83 9.64 10.17 19.58%
EY 7.51 6.02 5.66 6.77 5.31 10.37 9.83 -16.38%
DY 5.08 0.00 0.00 9.31 8.79 17.07 22.42 -62.73%
P/NAPS 1.35 1.36 1.40 1.23 1.36 1.24 1.27 4.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment